Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30th, 2024

Pursuant to article L-223-8 II of the French “code de Commerce” and 223-16 of the AMF’s General Regulations.

Regulatory News:

Median Technologies (Paris:ALMDT):

Total number of shares

18,418,233

Number of real voting rights* (excluding treasury shares**)

18,346,685

Theoretical number of voting rights* (including treasury shares**)

18,298,337

(*) Class E preference shares are non-voting (**) pursuant to article 223-11 of the AMF’s General Regulations

About Median Technologies: Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer diagnoses and cancer treatments. Median's offerings, including iCRO for medical image analysis and management in oncology trials and eyonis™, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. The French-based company, with a presence in the U.S. and China, is listed on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240510877847/en/

Median Technologies Emmanuelle Leygues Head of Corporate Marketing & Financial Communications [phone] [e-mail]

Press - ALIZE RP Caroline Carmagnol [phone] [e-mail]

Investors - ACTIFIN Ghislaine Gasparetto [phone] [e-mail]